Measurement of the internal dose to families of outpatients treated with 131I for hyperthyroidism

被引:19
|
作者
Barrington, S. F. [1 ]
Anderson, P. [2 ]
Kettle, A. G. [3 ]
Gadd, R. [4 ]
Thomson, W. H. [5 ]
Batchelor, S. [6 ]
Mountford, P. J. [4 ]
Harding, L. K. [5 ]
O'Doherty, M. J. [1 ]
机构
[1] St Thomas Hosp, PET Imaging Ctr, London SE1 7EH, England
[2] Queen Elizabeth Hosp, Dept Nucl Med, Birmingham B15 2TH, W Midlands, England
[3] E Kent Hosp NHS Trust, Kent & Canterbury Hosp, Dept Nucl Med, Canterbury, Kent, England
[4] Univ Hosp N Staffordshire, Directorate Med Phys & Clin Technol, Stoke On Trent, Staffs, England
[5] City Hosp, Dept Phys & Nucl Med, Birmingham, W Midlands, England
[6] Guys & St Thomas Hosp, Dept Med Phys, London SE1 9RT, England
关键词
Radiation dose; Radiation protection; Iodine radioisotopes; Thyroid gland; Hyperthyroidism therapy;
D O I
10.1007/s00259-008-0892-0
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective The aim of this study was to measure the internal dose received by family members from ingestion of radioactive contamination after outpatient therapy. Materials and methods Advice was given to minimise transfer of radioiodine. Home visits were made approximately 2, 7 and 21 days after treatment to measure radioactivity in the thyroids of family members. A decay correction was applied to radioactivity detected assuming ingestion had occurred at the earlier contact time, either the day of treatment or the previous home visit. An effective half-life of 6 or 7 days was used depending on age. Thyroid activity was summed if activity was found at more than one visit in excess of the amount attributable to radioactive decay. Effective dose (ED) was calculated using ICRP72. Results and discussion Fifty-three adults and 92 children, median age 12 (range 4-17) years participated. Median administered activity was 576 (range 329-690) MBq I-131. Thyroid activity ranged from 0 to 5.4 kBq in the adults with activity detected in 17. Maximum adult ED was 0.4 mSv. Thyroid activity ranged from 0 to 11.8 kBq in the children with activity detected in 26. The two highest values of 5.0 and 11.8 kBq occurred in children aged 5 and 14 years from different families. Eighty-five children had no activity or < 1 kBq detected. ED was < 0.2 mSv in 86 out of 92 children (93%). Previous published data showed 93% of children received an ED <= 0.8 mSv from external irradiation. Conclusion With advice, families of outpatients receiving radioiodine should be able to comply with statutory dose limits and constraints.
引用
收藏
页码:2097 / 2104
页数:8
相关论文
共 50 条
  • [31] I-131 UPTAKE IN TREATED HYPERTHYROIDISM
    BAUER, FK
    AMERICAN JOURNAL OF MEDICINE, 1952, 13 (04): : 502 - 502
  • [32] I-131 UPTAKE IN TREATED HYPERTHYROIDISM
    BAUER, FK
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1952, 223 (05): : 495 - 501
  • [33] WHEN AND HOW TO USE HIGHER 131I DOSES FOR HYPERTHYROIDISM
    HAMBURGER, JI
    PAUL, S
    NEW ENGLAND JOURNAL OF MEDICINE, 1968, 279 (25): : 1361 - +
  • [34] The influence of 131I therapy on thyroid volume in Graves' hyperthyroidism
    Pirnat, E
    Fidler, V
    Gaberscek, S
    Zaletel, K
    Hojker, S
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S465 - S465
  • [35] PROPANOLOL AND 131I IN TREATMENT OF DIFFUSE THYROID HYPERPLASIA WITH HYPERTHYROIDISM
    FRANCO, J
    COPPLER, M
    KOVALESK.B
    JOURNAL OF NUCLEAR MEDICINE, 1969, 10 (06) : 403 - +
  • [36] Effect of 131I on salivary glands function in 131I treated thyroid cancer patients
    Yuan, Z.B.
    Jin, C.Q.
    Yu, Y.L.
    Zhu, R.S.
    He Jishu/Nuclear Techniques, 2001, 24 (05):
  • [37] Consensus proposal on the use of 131I in hyperthyroidism and thyroid cancer
    Michaud, P
    REVISTA MEDICA DE CHILE, 1998, 126 (07) : 855 - 865
  • [38] Update on the utility of 131I for treatment of Graves hyperthyroidism.
    Shulkin, B
    Teytelboym, O
    Sisson, J
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 158P - 159P
  • [39] Thyroid remnant ablation with 1.1 GBq of 131I for outpatients
    Suzuki, K.
    Tsutsui, H.
    Suzuki, A.
    Yoshimura, M.
    Hashimoto, T.
    Uchida, K.
    Koizumi, K.
    Tokuuye, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S430 - S431
  • [40] Thyroid remnant ablation with 1110MBq of 131I in outpatients: measurement of effective dose to household members and establishment of safety precautions
    Yoshimura, M.
    Tsutsui, H.
    Ikeda, N.
    Koizumi, K.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 57 (01): : 101 - 108